The story of welfare reform in New York City shows how tested ideas can produce big changes in city policy, Thomas J. Main ...

Tania Markovic MBBS PhD FRACP; Jennifer L. Miller, MD; Elizabeth Roof, H.S.P., M.A.; and Theresa V. Strong, PhD; ...

November 18, 2025) - Adyton Resources Corporation (TSXV: ADY) (" Adyton " or the " Company ") is pleased to announce that its ...

Explore why power projects face chronic cost and schedule overruns and how digital tools, modular construction, and real-time ...

Rajant Corporation, the pioneer of Kinetic Mesh® wireless networking, today announced the launch of Rajant Guardian, a ...

Discover Telos Corporation's Q3 2025 earnings: record revenue growth, Xacta.ai launch, and raised outlook for 2026.

Topline results that were recently released from Sydnexis’s phase 3 Study of Atropine for the Reduction of Myopia Progression (STAR) trial of SYD-101 (atropine 0.01%) for slowing the progression of ...

-- 63% complete response (CR) rate at any time (n=62); -- 56% CR rate at 3 months (n=62); -- 62% CR rate at 6 months (n=37), with 4 patients having successfully converted to CR post reinduction; and - ...

Broadcast Retirement Network's Jeffrey Snyder discusses how to prevent cardiovascular disease at any age with Cone Health's ...

Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and provided a business update for the three and nine ...

In total, 56 verified koalas and 127 southern greater gliders were confirmed, equating to modelled abundance estimates of 147 koalas and 195 gliders across the overarching survey area. Mean densities ...

Pre-NDA meeting with FDA to discuss brilaroxazine's path to approval for schizophrenia planned in Q4 2025 - - Potential NDA submission for schizophrenia indication targeted for Q2 2026 - - European ...